Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
filingDate |
1991-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84465e81b450672eb32916bd954a6daf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f056d97b2f2d2c0594a0f1f4b202268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8d5f8e181f5153449ffec575b3f764f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc2d6bb43c74aa4d3420b2eb0b1e733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cebd3505fd1c79e8d56addb9a5f6ce74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a04759c9fe039b3b020114cdee07861 |
publicationDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2057711-C |
titleOfInvention |
Antibiotic agent |
abstract |
A new antibiotic cyclic lipopeptide having the formula (see formula I) wherein R is H or OH and a method of producing is described. The agent has very high activity against human pathogens and is of very low mammalian toxicity. |
priorityDate |
1990-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |